Literature DB >> 24425046

Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.

Matthew C Havrda1, Brenton R Paolella, Cong Ran, Karola S Jering, Christina M Wray, Jaclyn M Sullivan, Audrey Nailor, Yasuyuki Hitoshi, Mark A Israel.   

Abstract

Maturation defects occurring in adult tissue progenitor cells have the potential to contribute to tumor development; however, there is little experimental evidence implicating this cellular mechanism in the pathogenesis of solid tumors. Inhibitor of DNA-binding 2 (Id2) is a transcription factor known to regulate the proliferation and differentiation of primitive stem and progenitor cells. Id2 is derepressed in adult tissue neural stem cells (NSC) lacking the tumor suppressor Tp53 and modulates their proliferation. Constitutive expression of Id2 in differentiating NSCs resulted in maturation-resistant oligodendroglial precursor cells (OPC), a cell population implicated in the initiation of glioma. Mechanistically, Id2 overexpression was associated with inhibition of the Notch effector Hey1, a bHLH transcription factor that we here characterize as a direct transcriptional repressor of the oligodendroglial lineage determinant Olig2. Orthotopic inoculation of NSCs with enhanced Id2 expression into brains of mice engineered to express platelet-derived growth factor in the central nervous system resulted in glioma. These data implicate a mechanism of altered NSC differentiation in glioma development and characterize a novel mouse model that reflects key characteristics of the recently described proneural subtype of glioblastoma multiforme. Such findings support the emerging concept that the cellular and molecular characteristics of tumor cells are linked to the transformation of distinct subsets of adult tissue progenitors. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425046      PMCID: PMC5061294          DOI: 10.1158/0008-5472.CAN-13-1839

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Neural stem cells in the adult human brain.

Authors:  C B Johansson; M Svensson; L Wallstedt; A M Janson; J Frisén
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors.

Authors:  Yuanyuan Wu; Ying Liu; Edward M Levine; Mahendra S Rao
Journal:  Dev Dyn       Date:  2003-04       Impact factor: 3.780

3.  Embryonic stem cells as a platform for analyzing neural gene transcription.

Authors:  Xiaodong Zhang; Scott A Horrell; Deany Delaney; David I Gottlieb
Journal:  Stem Cells       Date:  2008-04-24       Impact factor: 6.277

4.  Postnatal mouse subventricular zone neuronal precursors can migrate and differentiate within multiple levels of the developing neuraxis.

Authors:  D A Lim; G J Fishell; A Alvarez-Buylla
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 5.  The cellular origin for malignant glioma and prospects for clinical advancements.

Authors:  Hui Zong; Roel G W Verhaak; Peter Canoll
Journal:  Expert Rev Mol Diagn       Date:  2012-05       Impact factor: 5.225

6.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

7.  The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Authors:  Shwetal Mehta; Emmanuelle Huillard; Santosh Kesari; Cecile L Maire; Diane Golebiowski; Emily P Harrington; John A Alberta; Michael F Kane; Matthew Theisen; Keith L Ligon; David H Rowitch; Charles D Stiles
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

8.  The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Authors:  Keith L Ligon; John A Alberta; Alvin T Kho; Jennifer Weiss; Mary R Kwaan; Catherine L Nutt; David N Louis; Charles D Stiles; David H Rowitch
Journal:  J Neuropathol Exp Neurol       Date:  2004-05       Impact factor: 3.685

9.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

10.  Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.

Authors:  Yasuyuki Hitoshi; Brent T Harris; Huan Liu; Brian Popko; Mark A Israel
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

View more
  15 in total

1.  Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.

Authors:  Jaclyn M Sullivan; Matthew C Havrda; Arminja N Kettenbach; Brenton R Paolella; Zhonghua Zhang; Scott A Gerber; Mark A Israel
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

2.  Oligodendroglia Are Particularly Vulnerable to Oxidative Damage after Neurotrauma In Vivo.

Authors:  Marcus K Giacci; Carole A Bartlett; Nicole M Smith; K Swaminathan Iyer; Lillian M Toomey; Haibo Jiang; Paul Guagliardo; Matt R Kilburn; Melinda Fitzgerald
Journal:  J Neurosci       Date:  2018-06-18       Impact factor: 6.167

3.  ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation.

Authors:  Roberta Azzarelli; Aoibheann McNally; Claudia Dell'Amico; Marco Onorati; Benjamin Simons; Anna Philpott
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

4.  Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.

Authors:  Josie Hayes; Helene Thygesen; Alastair Droop; Thomas A Hughes; David Westhead; Sean E Lawler; Heiko Wurdak; Susan C Short
Journal:  Oncoscience       Date:  2014-12-26

5.  ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function.

Authors:  Zhonghua Zhang; Gilbert J Rahme; Pranam D Chatterjee; Matthew C Havrda; Mark A Israel
Journal:  Cell Death Dis       Date:  2017-02-16       Impact factor: 8.469

6.  Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas.

Authors:  Prit Benny Malgulwar; Vikas Sharma; Ashutosh Singh Tomar; Chaitenya Verma; Aruna Nambirajan; Manmohan Singh; Vaishali Suri; Chitra Sarkar; Mehar Chand Sharma
Journal:  Oncotarget       Date:  2018-10-26

7.  NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease.

Authors:  Katharine M von Herrmann; Lucas A Salas; Eileen M Martinez; Alison L Young; Joseph M Howard; Mary S Feldman; Brock C Christensen; Owen M Wilkins; Stephen L Lee; William F Hickey; Matthew C Havrda
Journal:  NPJ Parkinsons Dis       Date:  2018-08-15

8.  KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.

Authors:  Xiaoyu Cheng; Ming Li; Xi Rao; Wenfeng Zhang; Xiaopeng Li; Liang Wang; Guanjun Huang
Journal:  Onco Targets Ther       Date:  2019-05-07       Impact factor: 4.147

9.  An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).

Authors:  A Tauziède-Espariat; M-A Debily; D Castel; J Grill; S Puget; M Sabel; K Blomgren; A Gareton; V Dangouloff-Ros; E Lechapt; N Boddaert; P Varlet
Journal:  Acta Neuropathol Commun       Date:  2019-06-10       Impact factor: 7.801

10.  Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination.

Authors:  Dennis H Lentferink; Jacomien M Jongsma; Inge Werkman; Wia Baron
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.